Esther McCorkindale, PA
Medical · Yakima, WANPI 1023005543
Payments from drug & device makers
Across 113 payments — averaging $24.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$1K
- Pfizer$155
- Sumitomo Pharma America, Inc.$115
- C. R. Bard, Inc. & Subsidiaries$95
- 180 Medical, Inc.$94
- Procept Biorobotics Corporation$85
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,45587%
- Education$36413%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 36 | $1,130 |
| Pfizer | 9 | $155 |
| Sumitomo Pharma America, Inc. | 5 | $115 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $95 |
| 180 Medical, Inc. | 5 | $94 |
| Procept Biorobotics Corporation | 1 | $85 |
| Alnylam Pharmaceuticals Inc. | 5 | $82 |
| Endo USA, Inc. | 3 | $80 |
| Boston Scientific | 3 | $72 |
| Urogen Pharma, Inc. | 2 | $69 |
| Merck | 2 | $66 |
| Urovant Sciences Inc | 2 | $53 |
| AbbVie | 3 | $52 |
| Bayer | 3 | $51 |
| Axonics, Inc. | 3 | $51 |
| Antares Pharma, Inc. | 3 | $50 |
| Tolmar, Inc. | 3 | $49 |
| Johnson & Johnson | 2 | $47 |
| Myriad Genetic Laboratories, Inc. | 3 | $47 |
| Myovant Sciences Inc. | 2 | $44 |
| Dendreon Pharmaceuticals LLC | 2 | $42 |
| Immunitybio, Inc. | 2 | $41 |
| Hollister Incorporated | 2 | $36 |
| Accord Healthcare, Inc. | 1 | $32 |
| Teleflex LLC | 1 | $25 |
| Progenics Pharmaceuticals, Inc. | 1 | $23 |
| Calyxo, Inc. | 1 | $23 |
| Olympus America Inc. | 1 | $21 |
| KARL Storz Endoscopy-america | 1 | $21 |
| Coloplast | 1 | $19 |
| Rochester Medical Corporation | 1 | $19 |
| Laborie Medical Technologies Corp. | 1 | $17 |
| SRS Medical Systems, Inc. | 1 | $14 |
How this compares
$2,820 in reported general payments places this provider in the 85th percentile of 457 medical providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Testosterone | 15 | $4,363 |
| Trospium Chloride | 26 | $2,157 |
| Tamsulosin Hcl | 67 | $1,091 |
| Testosterone Cypionate | 27 | $653 |
| Tolterodine Tartrate ErTolterodine Tartrate | 11 | $465 |
| Finasteride | 25 | $377 |
| Oxybutynin Chloride ErOxybutynin Chloride | 15 | $294 |
| Doxazosin Mesylate | 11 | $223 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $213 |
| Cephalexin | 27 | $206 |
Paid to pharmacies, not to this prescriber.
Other medical in Yakima
- Salvador LopezYakima$17K
- Diana McFarlaneSeattle$95K
- Karissa SecoraTacoma$53K
- Tori FranklinLakewood$23K
- Christian GarridoSpokane$22K
- Amy NelsonSeattle$15K
- Matthew PippengerCheney$14K
- Rebecca JohnsonSpokane$14K
- Jonathan CyphersBurien$13K
- Jonathan WhiteSeattle$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.